• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1

cafead

Administrator
Staff member
  • cafead   Apr 25, 2024 at 06:02: PM
via On Thursday, European drugmakers Sanofi and AstraZeneca announced several pipeline cuts in their respective first-quarter 2024 financial results, including assets to treat Sjögren’s syndrome and cardiovascular disease.

article source
 

<